Antibody-based drug for multiple sclerosis
A research team has developed an antibody with potential therapeutic effects against multiple sclerosis. The study paves the way for a new strategy to control the disease, say the scientists.

During previous work on a mouse model of stroke, the team from Inserm Unit 919 studied a factor involved in opening the blood-brain barrier, the NMDA receptor. In particular, they observed that blocking the interaction of this receptor with tPA (a member of the serine protease family) has beneficial effects associated with maintaining the integrity of the barrier.

https://www.sciencedaily.com/releases/2016/07/160719214834.htm
Like
Comment
Share